pioglitazone has been researched along with Brain Diseases in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkahloun, AG | 1 |
| Rodriguez, Y | 1 |
| Alaiyed, S | 1 |
| Wenzel, E | 1 |
| Saavedra, JM | 1 |
| Yin, QQ | 1 |
| Pei, JJ | 1 |
| Xu, S | 1 |
| Luo, DZ | 1 |
| Dong, SQ | 1 |
| Sun, MH | 1 |
| You, L | 1 |
| Sun, ZJ | 1 |
| Liu, XP | 1 |
2 other studies available for pioglitazone and Brain Diseases
| Article | Year |
|---|---|
Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARĪ³ Activation.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Brain Diseases; Cell Line; Down-Regulati | 2019 |
Pioglitazone improves cognitive function via increasing insulin sensitivity and strengthening antioxidant defense system in fructose-drinking insulin resistance rats.
Topics: Analysis of Variance; Animals; Brain Diseases; Fructose; Hyperinsulinism; Insulin; Insulin Resistanc | 2013 |